|
Iranian Journal of Pediatrics
Tehran University of Medical Sciences Press
ISSN: 1018-4406 EISSN: 2008-2150
Vol. 18, Num. 2, 2008, pp. 159-162
|
Iranian Journal of Pediatrics, Vol. 18, No. 2, June, 2008, pp. 159-162
Comparison
of Lipoprotein (a) and Apolipoproteins in Children with and without Familial History
of Premature Coronary Artery Disease
Azita Fesharakinia*1, MD, Pediatric Nephrologist; Toba Kazemi2, MD, Cardiologist; Asghar Zarban3, PhD of Biochemistry; Gholam Reza Sharifzadeh4,
MSc of Statistics
1
Department of
Pediatrics, Birjand University of Medical Sciences, Iran
2Departments of
Cardiology, Birjand University of Medical Sciences, Iran
3Department of
Biochemistry, Birjand University of Medical Sciences, Iran
4 Department of
Statistics, Birjand University of Medical Sciences, Iran
* Correspondence author;
Address: Department of pediatrics, Vali‐e‐Asr Hospital, Birjand, IR Iran
E‐mail: fesharakinia@yahoo.com
Received: 16/04/07; Revised: 01/1 0/07; Accepted: 15/12/07
Code Number: pe08025
Abstract
Objective: The importance of cardiovascular risk factors like
hypertension, obesity and dyslipidemia in prediction of later coronary artery disease (CAD) in offspring of
high-risk family is well known. This study was performed to compare the level
of lipoprotein (a) and apolipoproteinsas new risk factors in children
and adolescents with and without a family history of premature CAD.
Material & Methods: This case-control study was performed from November 2004 until
September 2005. All patients with premature myocardial infarction hospitalized
in the coronary care units (CCU) of Vali-e-Asr hospital, who survived and had
children between 2-14 years old, were defined as parents of the case group. 86
of them were chosen with simple non-random method. Only one child from each
family was selected randomly. The control group consisted of children with
nearest age and sex to children of the case group from the neighbors with
equivalent socioeconomic status, without a family history of premature
myocardial infarction. Subjects had been instructed to fast for 12 to 14 hours.
Venous blood was analyzed for lipoprotein (a) and Apolipoprotein A1 and B100.
Findings: The
level of lipoprotein (a) was significantly higher in the case group. There was
not a significant difference of lipoprotein levels between the two groups.
Conclusion: Measurement of lipoprotein (a) is recommended in screening
programs in offspring of high-risk families.
Key Words: Premature Myocardial Infarction, Risk
factors, Children, Lipoprotein (a), Apolipoproteins.
Introduction
Cardiovascular disease aggregates in families. This
is probably due in part to familial aggregation of important cardiovascular
risk factors[1,2]. So early screening and control of its risk
factors in offspring of high-risk families will help in the preventive works
from cardiovascular disease[3]. This is especially important for
those having a family history of premature coronary artery disease (CAD) (defined
as onset before the age of 55 years in a parent)[4]. The importance
of cardiovascular risk factors like hypertension, obesity and dyslipidemia in
prediction of latest CAD in these offspring are well known[5,6,7].
New risk factors, such as
fibrinogen, apolipoproteins, homocystein and lipoprotein (a) have been
identified and are under further investigation[6,8,9].
This study was performed in the city of Birjand, Northeastern Iran, to compare the level of lipoprotein (a), apolipoprotein A1 and
B100 in children with and without a positive familial history of premature
myocardial infarction (MI). The Research and Ethic Committee of Birjand
University of Medical Sciences approved this study protocol.
Material & Methods
This case-control study was performed from November
2004 until September 2005. All patients with premature myocardial infarction
hospitalized in the coronary care units (CCU) of the Vali-e-Asr hospital of the
Birjand University of Medical Sciences, survived and had children between
2-14 years old, weredefined as parents of the case group. 86 of them were chosen with simple non-random method.
Only one child from each family was selected randomly.
The control group consisted of children with
nearest age and sex to the children of the case group from the neighbors with
equivalent socioeconomic status without a family history of premature
myocardial infarction. Subjects had been instructed to fast for 12 to 14 hours.
Antecubital venous blood was collected. Biochemical tests including measurement
of lipoprotein (a) and apolipoprotein were carried out. An Elan outoanalyzer
was utilized for the determination of lipoprotein (a). Apolipoproteins (Apo A1,
Apo B100) were measured by spectrophotometery using the turbidometry method.
Statistical analyses were performed by the
SPSS statistical package using independent t-test and chi-square. P-values
less than 0.05 were considered as significant.
Findings
The populations of the case group and the control
group were equal (86 subjects). The mean age (SD) of case and control group
were 11.5 (2.5) and 11.8 (2.4) years respectively with no significant
difference. Forty four girls and 42 boys were in case group and 46 girls and 40
boys in control group with no significant difference.
Laboratory data are listed in table 1. Only
lipoprotein (a) level was significantly higher in case group than in control
group (P=0.005). The difference between boys and girls was not
significant (table 2). Apolipoprotein B100 was significantly higher in the
girls of the case group (P=0.01).
Table 1-
Laboratory data in the case and control group
Variable
(Mg/dl)
|
Cases
Mean
(SD)
|
Controls
Mean
(SD)
|
P value |
Lipoprotein
(a) |
30.8 (22.9) |
22
(17.2) |
0.005 |
Apo A1 |
104.5
(18.8) |
108.6
(15.5) |
NS* |
Apo B100 |
71.2
(14.8) |
70.9
(14.6) |
NS |
*NS: Not significant
Table 2- Laboratory data in the case and control groups according
to sex
Variable
(Mg/dl) |
Cases [Mean (SD)] |
Controls [Mean (SD)] |
Girls |
Boys |
P value |
Girls |
Boys |
P value |
Lipoprotein
(a) |
31.2 (25.80) |
30.4
(19.8) |
*NS |
22.3 (14.3) |
21.6 (20.2) |
NS |
Apo A1 |
103.7 (19.5) |
105.4
(18.2) |
NS |
106
(13.3) |
111.5 (17.3) |
NS |
Apo B100 |
75.2
(17.1) |
67.1 (10.6) |
0.01 |
71.3
(15.2) |
70.3 (14.1) |
NS |
* NS: Not
significant
Discussion
Atherosclerosis begins in childhood and progresses
to coronary artery disease (CAD) in adults. So it is important to pay more
attention to its risk factors from an early age. Several studies have showed
that the offspring of patients with premature coronary disease are at increased
risk for atherosclerosis[4,7,8]. Familial aggregation of
cardiovascular risk factors including hyper-tension, obesity and dislipidemia
have been extensively investigated[1,2]. It has been demonstrated
that both genetic and environmental factors contribute to the variability of
risk factors and their familial aggregation[10,11].
The aim of our study was to compare the level
of Lipoprotein (a), Apo A1 and Apo B100 in children with
and without family history of premature MI. Our study showed that lipoprotein
(a) was significantly higher in the case group. This supports the findings
reported by some others [14,15,16], but contradict the conclusions
reached by Barth et al[17].
Regarding apolipoproteins, Sniderman et al[12],
reported a higher Apo B100 level in the children of high-risk families
for CAD. Other studies[8,10] showed a higher level of Apo B100
and lower of Apo A1 in the children of patients with premature MI. Our
study did not find any significant difference in the concentrations of Apo B100
and Apo A1 between children of high-risk families and controls, but
Apo B100 was higher in the girls of high-risk families. Islam et al[17]
showed that a high Apo B100 level was associated with a positive
family history of CAD only in white girls.
Our study had some limitations. We did not
measure serum lipid profile and the effect of serum lipid value and Lipoprotein (a) level on each other. We could not study
the effect of age on serum level of Apo A1 and Apo B100 and Lipoprotein (a) in children with and without
family history of premature MI because we had limitation in the number of subjects
in the case and control group.
Conclusion
According to our findings, Lipoprotein (a) is a strong lipid
variable predisposing to coronary artery disease, so measurement of lipoprotein
(a) is recommended in screening programs for offspring (children and adolescents) with a positive history of
premature myocardial infarction.
Acknowledgment
The authors gratefully acknowledge the research
center of Birjand University of Medical Sciences for their support.
References
- Tershakovec
AM, Rader DJ. Disorders of lipoprotein metabolism and transport. In: Behrman
RE, Kilegman RM. Nelson Textbook of Pediatrics. 17th ed. Philadelphia, Saunders. 2004, P:445.
- Bao W,
Srinivasan SR, Valdez R, et al. Longitudinal changes in cardiovascular risk from childhood
to young adulthood in offspring of parents with coronary artery disease: the
Bogalusa Heart Study. JAMA. 1997;278(21):1749-54.
-
Berenson
GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors
and atherosclerosis in children and young adults. N Engl J Med. 1998;338(23):1650-6.
-
Szamosi
T, Murber A, Szamosi T Jr, et al. Atherosclerosis risk factors in children of high-risk
families. Acta Physiol Hung. 1999;86(93-4):185-90.
-
De Bacquer D,
De Backer G, Kornitzer M, Blackburn H. Parental history of premature coronary
heart disease mortality and signs of ischemia on the resting electrocardiogram.
J Am Coll Cardiol. 1999;33(6):1491-8.
-
Slack J, Evans
KA. The increased risk of death from ischaemic heart disease in the first
degree relatives of 121 men and 96 women with ischaemic heart disease. J Med
Genet. 1966;3(4):239-57.
- Widhalm
K, Koch S, Pakosta R, et al. Serum lipids, lipoproteins and apolipoproteins in children with and
without familial history of premature coronary heart disease. J Am Coll Nutr.
1992;11(suppl 1):32S-35S.
-
Kelishadi R, Sarraf
Zadegan N, Nadery GhA, et al. Atherosclerosis risk factors in children and
adolescents with or without family history of premature coronary artery
disease. Med Sci Monit. 2002;8(6): 425-9.
- Winkleby MA,
Robinson TN, Sundquist J, Kraemer HC. Ethnic variation in cardiovascular
disease risk factors among children and young adults: Findings from the Third
National Health and Nutrition Examination Survey, 19881994. JAMA. 1999; 281(11):100613.
- Beigel
Y, George J, Leibovici L, et al. Coronary risk factors in children of parents with
premature coronary artery disease. Acta Paediatr. 1993;82(2):162-5.
- Barth
JA, Deckelbaum RJ, Stare JT, et al. Family history of early cardiovascular disease in children
with moderate to severe hypercholesterolemia: relationship to lipoprotein (a)
and lowdensity lipoprotein cholesterol levels. J Lab Clin Med. 1999;133(3):237-44.
-
Sniderman A,
Teng B, Genest J, et al. Familial aggregation and early expression of
hyperapobetalipoproteinemia. Am J Cardiol. 1985;55(4):291-5.
- Chotivittayatatarakorn
P, Chewataworn A, Sathapoldeja R, Sirimonkol P. Hyperlipidemia in children at
risk for coronary heart disease. Med Assoc Thai. 2003;86(2):195-200.
- Abde
Yazdan Z, Sadeghy N, Hassanpoor M, et al. The risk factors of cardiovascular disease in children
with type 1 diabetes. Res Med Sci J. 2003;8(1):38-41.
- Kelishadi R,
Hashemipoor M, Amir M, Saraf-zadegan N. Trend of atherosclerosis risk factors
in children of Isfahan. Aoex. 2001;9(1):36-70.
-
Kelishadi
R, Pour MH, Zadegan NS, et al. Dietary fat intake and lipid profiles of Iranian adolescents: Isfahan
Healthy Heart Program-Heart Health promotion from childhood. Prev Med. 2004;39(4):
760-6.
- Glowinska B,
Urban M, Koput A. Cardiovascular risk factors in children with obesity,
hypertension and diabetes: lipoprotein (a) levels and body mass index correlate
with family history of cardiovascular disease. Eur J Pediatr.
2002;161(10):511-8.
- Chu
NF, Rimm EB, Wang DJ, al. Clustering of cardiovascular disease risk factors among obese
schoolchildren: the Taipei Children Heart Study. Am J Clin Nutr. 1998;67(6):1141-6.
© Copyright 2008 - TUMS PUBLICATIONS
|